Institutional investors purchased a net $1.6 million shares of NNVC during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 7.49% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RAMIUS ADVISORS LLC Bought 373.8 Thousand shares of NanoViricides Inc
WHARTON BUSINESS GROUP LLC Bought 363.5 Thousand shares of NanoViricides Inc
TFS CAPITAL LLC Bought 230.5 Thousand shares of NanoViricides Inc